We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$915M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$161M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$78.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$56.9M |
| 5 |
AstraZeneca
AZN
|
+$53.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$170M |
| 2 |
AT&T
T
|
+$142M |
| 3 |
Microsoft
MSFT
|
+$136M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
1951
DELISTED
Catalyst Pharmaceutical
CPRX
| $151K | ﹤0.01% |
18,208
-3,008
| -14% | -$21.3K |
|
|
ONL
1952
Orion Office REIT
ONL
$148M
| $151K | ﹤0.01% |
10,820
+159
| +1% | +$2.68K |
|
1953
Atea Pharmaceuticals
AVIR
$379M
| $150K | ﹤0.01% |
20,721
-5,104
| -20% | -$34.7K |
|
|
AFMD
1954
DELISTED
Affimed
AFMD
| $149K | ﹤0.01% |
3,416
-807
| -19% | -$35.1K |
|
1955
Rigel Pharmaceuticals
RIGL
$680M
| $149K | ﹤0.01% |
4,973
-1,168
| -19% | -$31.6K |
|
1956
Nurix Therapeutics
NRIX
$2.43B
| $148K | ﹤0.01% |
10,489
-2,639
| -20% | -$46.8K |
|
|
CLDT
1957
Chatham Lodging
CLDT
$630M
| $147K | ﹤0.01% |
10,665
-1,312
| -11% | -$18K |
|
1958
Heartland Express
HTLD
$1.11B
| $147K | ﹤0.01% |
10,457
-1,285
| -11% | -$19.1K |
|
1959
Yext
YEXT
$501M
| $147K | ﹤0.01% |
21,421
-3,183
| -13% | -$24.3K |
|
|
BRSP
1960
BrightSpire Capital
BRSP
$681M
| $146K | ﹤0.01% |
15,831
-2,615
| -14% | -$24.2K |
|
1961
SiriusPoint
SPNT
$2.98B
| $146K | ﹤0.01% |
19,599
-2,482
| -11% | -$19.6K |
|
1962
Caribou Biosciences
CRBU
$156M
| $145K | ﹤0.01% |
15,766
+2,856
| +22% | +$30.1K |
|
1963
Monte Rosa Therapeutics
GLUE
$1.92B
| $144K | ﹤0.01% |
+10,230
| New | +$142K |
|
1964
Workhorse Group
WKHS
$29.5M
| $144K | ﹤0.01% |
10
+1
| +11% | +$11K |
|
|
AMRS
1965
DELISTED
Amyris Inc.
AMRS
| $144K | ﹤0.01% |
33,159
-5,478
| -14% | -$24.6K |
|
1966
ARKO Corp
ARKO
$890M
| $142K | ﹤0.01% |
15,627
-10,751
| -41% | -$90.6K |
|
1967
MeiraGTx Holdings
MGTX
$1.09B
| $142K | ﹤0.01% |
10,186
-2,575
| -20% | -$39.7K |
|
1968
Bionano Genomics
BNGO
$12.7M
| $141K | ﹤0.01% |
91
-15
| -14% | -$20.2K |
|
|
TDAY
1969
USA Today Co
TDAY
$1.23B
| $141K | ﹤0.01% |
31,345
-3,859
| -11% | -$19.6K |
|
|
GRFS
1970
Grifois
GRFS
$5.16B
| $140K | ﹤0.01% |
11,962
-4,154
| -26% | -$47.8K |
|
|
MTTR
1971
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $140K | ﹤0.01% |
17,313
+4,031
| +30% | +$38.2K |
|
1972
Acco Brands
ACCO
$369M
| $139K | ﹤0.01% |
17,476
-2,860
| -14% | -$23.7K |
|
1973
Lifestance Health
LFST
$4.16B
| $136K | ﹤0.01% |
+13,478
| New | +$118K |
|
|
AMRN
1974
Amarin Corp
AMRN
$284M
| $134K | ﹤0.01% |
2,041
-709
| -26% | -$46.8K |
|
1975
Evolus
EOLS
$394M
| $134K | ﹤0.01% |
11,978
-3,101
| -21% | -$26.4K |
|
Similar funds
ProShare Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
- ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
- ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
- ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
- ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
- ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
- ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.
Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.